Literature DB >> 22092501

Association of XRCC1, XRCC3, and NAT2 polymorphisms with the risk of oral submucous fibrosis among eastern Indian population.

Sanjit Mukherjee1, Aneek Das Bhowmik, Paromita Roychoudhury, Kanchan Mukhopadhyay, Jay Gopal Ray, Keya Chaudhuri.   

Abstract

BACKGROUND: Arecanut and smokeless tobacco usage is a major cause for oral submucous fibrosis (OSF) and its subsequent development to oral squamous cell carcinoma in South-east Asian population. Polymorphisms at N-acetyltransferase 2 locus, coding for an enzyme catalyzing acetylation of aromatic amines, might cause DNA adduct formation because of improper acetylation of these polyaromatic hydrocarbons. DNA repair enzymes remove these adduct to prevent malignancy.
METHODS: In this hospital-based study, 100 controls and 88 OSF patients were genotyped at four polymorphic sites on NAT2 481 (C > T; silent), 590 (G > A; Arg197 > Gln), 803 (A > G; Lys268 > Arg), 857 (G > A; Gly286 > Glu) and two on XRCC1 18067 (C > T Arg 194 > Trp), 28152 (G > A Arg 399 > Gln), and one of XRCC3 26304 (C > T Thr 241 > Met) loci by PCR-RFLP to determine the risk of the disease.
RESULTS: Heterozygous XRCC3 codon 241 [OR 2.07 (1.05-4.06)], homozygous variant of NAT C481T [OR 2.81 (1.09-7.21)], and both heterozygous and homozygous variants of NAT codon 268 and 286 [OR 2.31 (1.20-4.45) and 4.98 (1.87-13.14), and 6.12 (2.75-13.62) and 2.65 (1.04-6.72)] individually influenced susceptibility to OSF in the population.
CONCLUSION: Gene-gene interaction analysis by multifactor dimensionality reduction (MDR) revealed that XRCC3 Thr 241 Met had the largest univariate effect followed by XRCC3 Thr 241 Met - NAT2 A857G in men that presents a highly synergistic interaction as one of the potential combinations of single nucleotide polymorphisms (SNPs) to increase the risk of OSF in men if exposed to arecanut or smokeless tobacco usage. These observations can speculate the impact of the studied SNPs on the etiology of OSF.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22092501     DOI: 10.1111/j.1600-0714.2011.01097.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  6 in total

1.  N-acetyltransferase 2 genetic variants confer the susceptibility to head and neck carcinoma: evidence from 23 case-control studies.

Authors:  Liang Zhang; Zhaolan Xiang; Rui Hao; Ru Li; Yi Zhu
Journal:  Tumour Biol       Date:  2013-12-13

2.  Comprehensive SNP scan of DNA repair and DNA damage response genes reveal multiple susceptibility loci conferring risk to tobacco associated leukoplakia and oral cancer.

Authors:  Pinaki Mondal; Sayantan Datta; Guru Prasad Maiti; Aradhita Baral; Ganga Nath Jha; Chinmay Kumar Panda; Shantanu Chowdhury; Saurabh Ghosh; Bidyut Roy; Susanta Roychoudhury
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

3.  Comparative distribution of Lysyl Oxidase (G473A) and NQO1 (C609T) polymorphism among tea-garden workers (habitual chewers of betel quid) of Darjeeling district and Kolkata city of West Bengal.

Authors:  Jay Gopal Ray; Sanjit Mukherjee; Basudev Mahato; B H Sripathi Rao; Keya Chaudhuri
Journal:  Contemp Clin Dent       Date:  2013-10

4.  Whole transcriptome sequencing identifies tumor-specific mutations in human oral squamous cell carcinoma.

Authors:  Qu Zhang; Jun Zhang; Hong Jin; Sitong Sheng
Journal:  BMC Med Genomics       Date:  2013-09-04       Impact factor: 3.063

5.  Characterization of a Novel Dermal Fibrosis Model Induced by Areca Nut Extract that Mimics Oral Submucous Fibrosis.

Authors:  Min-Hsuan Chiang; Ping-Ho Chen; Yuk-Kwan Chen; Chia-Hsin Chen; Mei-Ling Ho; Yan-Hsiung Wang
Journal:  PLoS One       Date:  2016-11-16       Impact factor: 3.240

Review 6.  Single nucleotide polymorphisms as markers of genetic susceptibility for oral potentially malignant disorders risk: Review of evidence to date.

Authors:  Krithiga Shridhar; Aastha Aggarwal; Gagandeep Kaur Walia; Smriti Gulati; A V Geetha; D Prabhakaran; Preet K Dhillon; Preetha Rajaraman
Journal:  Oral Oncol       Date:  2016-10       Impact factor: 5.337

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.